Mereo BioPharma Group PLC (MREO)
3.53
-0.29
(-7.59%)
USD |
NASDAQ |
Nov 15, 16:00
3.525
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Revenue (Annual): 10.00M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 10.00M |
December 31, 2022 |
Date | Value |
---|---|
December 31, 2021 | 49.21M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
10.00M
Minimum
2023
49.21M
Maximum
2021
29.61M
Average
29.61M
Median
Revenue (Annual) Benchmarks
NuCana PLC | -- |
TC BioPharm (Holdings) PLC | -- |
Biodexa Pharmaceuticals PLC | 0.4741M |
Adaptimmune Therapeutics PLC | 60.28M |
Bicycle Therapeutics PLC | 26.98M |